The Impact of Innovation on the Performance of Health Care in the Economic Security System of the Region
DOI:
https://doi.org/10.17059/2019-1-13Keywords:
transformational change, health system, e-health, oncology service, innovation, public-private partnership, sustainability, social and economic development, region, economic securityAbstract
A breakthrough in innovations largely depends on the quality of human potential. In the context of demographic threats for economic security of the region, the national project “Healthcare” has prepared measures for reducing the mortality of the working age population, including mortality from cancer. However, the costs of cancer detection and treatment, as well as social costs of temporary disability are later compensated by reduced mortality losses and increased contribution of the labour potential to gross regional product (GRP). During the research we applied systematic and integrative approaches, methods of comparative and statistical analysis using modern IT solutions. The research is based on the data from oncology services of Tyumen and Sverdlovsk regions. The organizational and medical innovations in Tyumen region, including modern diagnostics on the basis of radiological centre, have increased the detection rate of malignant neoplasm. Moreover, these innovations have significantly reduced the number of cancer-related deaths in comparison with the national average value. In 2017, this indicator per 100 thousand was 112.78 in the Russian Federation, while in Tyumen region it was 90.04. For the period from 2013 to 2017, improvements in diagnostics and quality of the oncology service in Sverdlovsk region contributed to a higher detection of various diseases, longer treatment in the hospital and at home, which did not allow achieving economic effects by reducing costs. However, these measures have led to significant reduction of damage from working age population mortality. An indicator of “multidimensional economic effect in health care” is calculated as the sum of various types of effects. Its value demonstrates compensation for costs incurred at certain stages of medical assistance with the effects resulting from preservation of human potential by reducing mortality. Our forecast shows that medical and demographic indicators of the oncology service of the Sverdlovsk region will improve by 2022. Such improvements will result from constructing and equipping the centre of nuclear medicine and the proton centre in the framework of the public-private partnership in Sverdlovsk region healthcare. The results of the study can be applied for an objective assessment of health care and its contribution to the regional economy.References
Sukhova, O. V. (2018). Simulyakry v ekonomike Rossii [Russian economy’s simulacra]. Diskussiya [Discussion], 90,
6–14. DOI: 10.24411/2077–7639–2018–10001 (In Russ.)
Sachs, J. D. (2011). Konets bednosti. Ekonomicheskie vozmozhnosti nashego vremeni [Th e end of poverty: Economic possibilies for our time]. Trans. from English. M: Gaidar Institute Publ., 424.
Zaikina, G. (2018). Robotizirovannye sistemy v meditsine: kakimi im byt? [Robotic systems in medicine: what should they be?]. Vestnik Rossiyskoy Akademii nauk [Herald of the Russian Academy of Sciences], 88(9), 785–792. DOI: 10.31857/ S086958730001691–8 (In Russ.)
Boyarintsev, B. I. & Rozhkova, E. V. (2014). Innovatsionnyy mekhanizm fi nansirovaniya zdravookhraneniya [Innovative mechanism of the interaction of fi nancial sources of medical services]. Audit i fi nansovyy analiz [Audit and fi nancial analysis], 5, 408–410. (In Russ.)
Gladkov, K. V. (2016). Gosudarstvenno-chastnoe partnerstvo kak istochnik kompetentsiy chastnogo partnera v zdravookhranenii [Public-private partnerships as a source of private partner’s competence in health care]. Sovremennye problemy nauki i obrazovaniya [Modern problems of science and education], 2. Retrieved from http://www.science-education.ru/ru/article/view?id=24359 (Date of access: 18.01.2019). (In Russ.)
Roehrich, J. K., Lewis, M. A. & George, G. (2014). Are public–private partnerships a healthy option? A systematic literature review. Social Science & Medicine, 113, 110–119. DOI: 10.1016/j.socscimed.2014.03.037.
Kostyak, L., Shaw, D., Elger, B. & Annaheim, B. (2017). A means of improving public health in low- and middle-income countries? Benefi ts and challenges of international public–private partnerships. Public Health, 149, 120–129. DOI: 10.1016/j.puhe.2017.03.005.
Bonfi m, L. R., Segatto, A. P. & Gonçalves, S. A. (2018). A conical-helix model of technology transfer and public-private partnerships for technological development in Brazilian public health. Technology in Society, 53, 110–123. DOI: 10.1016/j. techsoc.2018.01.006.
Th adani, K. B. (2014). Public Private Partnership in the Health Sector: Boon or Bane. Procedia — Social and Behavioral Sciences, 157, 307–316. DOI: 10.1016/j.sbspro.2014.11.033.
Buso, M., Marty, F. & Tran, P. T. (2017). Public-private partnerships from budget constraints: Looking for debt hiding? International Journal of Industrial Organization, 51, 56–84. DOI: 10.1016/j.ijindorg.2016.12.002
Chauhan, Y. & Marisetty, V. B. (2018). Do public-private partnerships benefi t private sector? Evidence from an emerging market. Research in International Business and Finance, 47, 563–579 DOI: 10.1016/j.ribaf.2018.10.002.
Comendeiro-Maaløe, M., Ridao-López, M., Gorgemans, S. & Bernal-Delgado, E. (2018). A comparative performance analysis of a renowned Public Private Partnership for health care provision in Spain between 2003 and 2015. Health Policy. DOI: 10.1016/j.healthpol.2018.11.009
Galea, G. & Mckee, M. (2014). Public–private partnerships with large corporations: Setting the ground rules for better health. Health Policy, 115(2–3), 138–140. DOI: 10.1016/j.healthpol.2014.02.003.
Kretser, A., Murphy, D. & Starke-Reed, P. (2017). A partnership for public health: USDA branded food products database. Journal of Food Composition and Analysis, 64, 10–12. DOI: 10.1016/j.jfca.2017.07.019.
Lee, H. S. (2013). A Study on the Public-Private Partnership to Global Health Issues in Korea. Osong Public Health and Research Perspectives, 4(6), 308–315. DOI: 10.1016/j.phrp.2013.10.003
Medhekar, A. (2014). Public-private Partnerships for Inclusive Development: Role of Private Corporate Sector in Provision of Healthcare Services. Procedia — Social and Behavioral Sciences, 157, 33–44. DOI: 10.1016/j.sbspro.2014.11.007.
Solana, E. F. (2014). Public Private Not-for-profi t Partnerships: Delivering Public Services to Developing Countries. Procedia Engineering, 78, 259–264. DOI: 10.1016/j.proeng.2014.07.065.
Torchia, M., Calabrò, A. & Morner, M. (2013). Public–Private Partnerships in the Health Care Sector: A systematic review of the literature. Public Management Review, 17(2), 236–261. DOI: 10.1080/14719037.2013.792380.
Wong, E. L., Yeoh, E., Chau, P. Y., Yam, C. H., Cheung, A. W. & Fung, H. (2015). How shall we examine and learn about public-private partnerships (PPPs) in the health sector? Realist evaluation of PPPs in Hong Kong. Social Science & Medicine, 147, 261–269. DOI: 10.1016/j.socscimed.2015.11.012.
Santandrea, M., Bailey, S. & Giorgino, M. (2015). Value for money in UK healthcare public–private partnerships: A fragility perspective. Public Policy and Administration, 31(3), 260–279. DOI: 10.1177/0952076715618003.
Trofi mova, T. (2018). Tsifrovye tekhnologii v meditsine Sverdlovskoy oblasti [Digital technologies in medicine of Sverdlovsk oblast]. Materialy Vtorogo Evraziyskogo kongressa s mezhdunarodnym uchastiem «Innovatsii v meditsine: obrazovanie, nauka, praktika» [Materials of the Second Eurasian Congress with international participation «Innovations in medicine: education, science, practice»], Ekaterinburg. Retrieved from: http://www.2mforum.ru/projects/evraziyskiy_kongress_innovatsii_v_meditsine_obrazovanie_nauka_praktika/informatsionnoe_pismo (Date of access: 16.01.2019). (In
Russ.)
Ogryzko, E. V., Shelepova E. A. & Tyurina, E. M. (2018). Dinamika smertnosti naseleniya Rossiyskoy Federatsii za 2012–2016 gody [Th e dynamics of mortality of the population of the Russian Federation from 2012–2016]. Menedzher zdravookhraneniya [Manager of health care], 9, 50–61. (In Russ.)
Oshchepkov, V. N. (2018). Mesto yadernoy meditsiny v lechenii onkologicheskogo bolnogo [Nuclear medicine in the treatment of cancer patients]. Materialy Vtorogo Evraziyskogo kongressa s mezhdunarodnym uchastiem «Innovatsii v meditsine: obrazovanie, nauka, praktika» [Materials of the Second Eurasian Congress with international participation «Innovations in medicine: education, science, practice»], Ekaterinburg. Retrieved from: http://www.2mforum.ru/projects/ evraziyskiy_kongress_innovatsii_v_meditsine_obrazovanie_nauka_praktika/informatsionnoe_pismo (Date of access:
16.01.2019). (In Russ.)
Elishev, V. G. (2018). Perspektivy razvitiya yadernoy meditsiny v Sverdlovskoy oblasti [Prospects for the development of nuclear medicine in Sverdlovsk oblast]. Materialy Vtorogo Evraziyskogo kongressa s mezhdunarodnym uchastiem «Innovatsii v meditsine: obrazovanie, nauka, praktika» [Materials of the Second Eurasian Congress with international participation «Innovations in medicine: education, science, practice»], Ekaterinburg. Retrieved from: http://www.2mforum. ru/projects/evraziyskiy_kongress_innovatsii_v_meditsine_obrazovanie_nauka_praktika/informatsionnoe_pismo (Date of access: 16.01.2019). (In Russ.)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Natalya Vasilyevna Krivenko, Vladimir Gennadevich Elishev, Lyudmila Anatolevna Kriventsova
This work is licensed under a Creative Commons Attribution 4.0 International License.
